Obliterative bronchiolitis

Research output: Contribution to journalReview article

83 Citations (Scopus)

Abstract

Obliterative bronchiolitis following lung transplantation is common and potentially devastating. Its exact cause is undefined, but multiple immune and nonimmune processes contribute to its pathogenesis. Severe acute rejection and recurrent acute rejection have been shown to confer the greatest risk for obliterative bronchiolitis, signifying the central importance of alloimmunity in the disease process. Treatment of established disease with intensification of immune suppression has been of limited benefit, so current clinical strategies include early detection and minimization of risk. As our understanding of the disease evolves, it is hoped that effective interventions targeted at specific pathogenetic steps will emerge. In the meantime, obliterative bronchiolitis remains the most important and sinister long-term complication of lung transplantation.

Original languageEnglish (US)
Pages (from-to)319-338
Number of pages20
JournalClinics in Chest Medicine
Volume18
Issue number2
DOIs
StatePublished - Jan 1 1997

Fingerprint

Bronchiolitis
Lung Transplantation

Cite this

Obliterative bronchiolitis. / Kelly, K.; Hertz, Marshall I.

In: Clinics in Chest Medicine, Vol. 18, No. 2, 01.01.1997, p. 319-338.

Research output: Contribution to journalReview article

Kelly, K. ; Hertz, Marshall I. / Obliterative bronchiolitis. In: Clinics in Chest Medicine. 1997 ; Vol. 18, No. 2. pp. 319-338.
@article{4c349eea4fe14faf873a348d166a2af8,
title = "Obliterative bronchiolitis",
abstract = "Obliterative bronchiolitis following lung transplantation is common and potentially devastating. Its exact cause is undefined, but multiple immune and nonimmune processes contribute to its pathogenesis. Severe acute rejection and recurrent acute rejection have been shown to confer the greatest risk for obliterative bronchiolitis, signifying the central importance of alloimmunity in the disease process. Treatment of established disease with intensification of immune suppression has been of limited benefit, so current clinical strategies include early detection and minimization of risk. As our understanding of the disease evolves, it is hoped that effective interventions targeted at specific pathogenetic steps will emerge. In the meantime, obliterative bronchiolitis remains the most important and sinister long-term complication of lung transplantation.",
author = "K. Kelly and Hertz, {Marshall I}",
year = "1997",
month = "1",
day = "1",
doi = "10.1016/S0272-5231(05)70382-8",
language = "English (US)",
volume = "18",
pages = "319--338",
journal = "Clinics in Chest Medicine",
issn = "0272-5231",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Obliterative bronchiolitis

AU - Kelly, K.

AU - Hertz, Marshall I

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Obliterative bronchiolitis following lung transplantation is common and potentially devastating. Its exact cause is undefined, but multiple immune and nonimmune processes contribute to its pathogenesis. Severe acute rejection and recurrent acute rejection have been shown to confer the greatest risk for obliterative bronchiolitis, signifying the central importance of alloimmunity in the disease process. Treatment of established disease with intensification of immune suppression has been of limited benefit, so current clinical strategies include early detection and minimization of risk. As our understanding of the disease evolves, it is hoped that effective interventions targeted at specific pathogenetic steps will emerge. In the meantime, obliterative bronchiolitis remains the most important and sinister long-term complication of lung transplantation.

AB - Obliterative bronchiolitis following lung transplantation is common and potentially devastating. Its exact cause is undefined, but multiple immune and nonimmune processes contribute to its pathogenesis. Severe acute rejection and recurrent acute rejection have been shown to confer the greatest risk for obliterative bronchiolitis, signifying the central importance of alloimmunity in the disease process. Treatment of established disease with intensification of immune suppression has been of limited benefit, so current clinical strategies include early detection and minimization of risk. As our understanding of the disease evolves, it is hoped that effective interventions targeted at specific pathogenetic steps will emerge. In the meantime, obliterative bronchiolitis remains the most important and sinister long-term complication of lung transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0030912712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030912712&partnerID=8YFLogxK

U2 - 10.1016/S0272-5231(05)70382-8

DO - 10.1016/S0272-5231(05)70382-8

M3 - Review article

C2 - 9187825

AN - SCOPUS:0030912712

VL - 18

SP - 319

EP - 338

JO - Clinics in Chest Medicine

JF - Clinics in Chest Medicine

SN - 0272-5231

IS - 2

ER -